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Summary
This report presents information about the prevalence and characteristics of children aged 0–14 with type 1 
diabetes in Australia, based on data from the 2013 National (insulin-treated) Diabetes Register (NDR). This is the  
first time national statistics on the prevalence of type 1 diabetes among children aged 0–14 have been reported  
by the NDR.
Type 1 diabetes is a non-preventable lifelong autoimmune disease, which is most commonly diagnosed in 
children. It is a difficult condition to manage, and if left untreated or improperly managed, can lead to many 
health complications or death. 
Ongoing, regular monitoring of type 1 diabetes is essential to improve Australia’s ability to respond to this 
important health problem.
In 2013, 6,091 children aged 0–14 had type 1 diabetes in Australia—representing  
139 cases per 100,000 population, or about 1 in every 720 children in that age group.
Rates of type 1 diabetes were similar for both boys and girls.
Rates for children aged 10–14 were twice as high (278 cases per 100,000 population) 
as for children aged 5–9 (123 per 100,000), and more than 10 times as high as for 
children aged 0–4 (27 per 100,000).
The Northern Territory had the lowest prevalence of type 1 diabetes in children (50 
cases per 100,000 population), while Tasmania had the highest (166 per 100,000).
Children living in Remote and very remote areas had the lowest prevalence of  
type 1 diabetes (82 cases per 100,000 population) compared with all other areas in 
Australia (where rates varied between 133 and 169 cases per 100,000 population).
The prevalence of type 1 diabetes among children was relatively similar across 
socioeconomic groups.
There were 167 Aboriginal and Torres Strait Islander children with type 1 diabetes—
equating to 69 cases per 100,000 Indigenous children, or 1 in almost 1,500.
Just over 2 in 5 children (43%) with type 1 diabetes used a pump to administer insulin.
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Introduction
This report examines the number (prevalence) of children aged 0–14 with type 1 diabetes in Australia in 2013.  
It is the first national report to present this information, and builds on a previous AIHW report, which presented  
a combination of existing data for children aged 0–9 and projected data for children aged 10–14 (AIHW 2011).
The results are part of ongoing national reporting from the National (insulin-treated) Diabetes Register (NDR),  
which was established in 1999 and captures data about people who use insulin to treat and manage their 
diabetes. See Appendix B for further information about the NDR. For those aged under 15, the NDR is ascertained 
from 2 data sources—the National Diabetes Services Scheme (NDSS) and the Australasian Paediatric Endocrine 
Group (APEG). As a result, it captures almost all children with type 1 diabetes in Australia (AIHW 2015b). 
What is type 1 diabetes?
Type 1 diabetes is a chronic autoimmune disease that develops when the immune system destroys the  
insulin-producing cells of the pancreas (see Box 1 for further details). While type 1 diabetes can occur at any age, 
it mainly develops during childhood and adolescence (Craig et al. 2011). For example, in 2013, 44% of all newly 
diagnosed cases of type 1 diabetes were in children aged 0–14 (AIHW 2015a), despite children in this age group 
accounting for only 19% of the total population. 
The cause of type 1 diabetes is unknown, but it is believed to be an interaction of genetic predisposition and 
environmental factors. Currently there is no way to prevent or cure type 1 diabetes. Without adequate ongoing 
management, the condition results in various short- and long-term health complications, and in some cases, 
unconsciousness or death.
Burden of type 1 diabetes
Diagnosis with type 1 diabetes early in life has implications for the individual, their families and society as a whole.  
For those living with type 1 diabetes, the condition can result in substantial morbidity, premature death and  
disability, and has an impact on emotional wellbeing and quality of life. It also places a heavy burden on those  
who support them. 
At a health system level, the cost of type 1 diabetes is around $570 million annually, with per person costs 
increasing significantly for people with health complications as a result of their type 1 diabetes (Baker IDI Heart 
and Diabetes Institute 2012).
Type 1 diabetes is difficult to manage, particularly in children, requiring a careful balance of diet, exercise and 
insulin intake. As a result, many children have suboptimal glycaemic control (Craig et al. 2002), which increases 
the risk of complications. Prolonged duration of type 1 diabetes, especially where blood glucose levels have 
fluctuated, results in diabetes-related complications becoming increasingly common over time (Craig et al. 2011). 
Therefore children diagnosed at a young age are at a greater risk of developing complications compared with 
those diagnosed later in life (Craig et al. 2002).
Given the considerable burden of type 1 diabetes among children, monitoring is essential to improve Australia’s 
ability to respond to this important health problem. The information in this report may inform the effective 
planning of treatment and support services, and the cost-effective allocation of resources to improve outcomes 
for those with type 1 diabetes.
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Box 1: Type 1 diabetes
What is it?
Type 1 diabetes is a chronic autoimmune disease that develops when the immune system destroys the  
insulin-producing cells of the pancreas. Without insulin, glucose cannot be transported into the cells (where 
it would usually be stored for future energy use), so blood glucose levels rise. The cause of type 1 diabetes is 
unknown, although it is believed to be an interaction of genetic predisposition and environmental factors.
What are the complications?
The objective of type 1 diabetes management is to keep blood glucose levels within a normal range. Poor 
glycaemic control—where blood glucose levels fluctuate beyond a recommended range—is associated 
with both short- and long-term health complications.
Short-term complications of type 1 diabetes include: hypoglycaemia (low blood sugar); hyperglycaemia 
(high blood sugar); ketoacidosis (a life-threatening condition due to inadequate administration of insulin, 
leading to profound disturbance of the metabolism, and a build-up of acids in the blood); increased 
susceptibility to infections; and a reduced ability to heal. Over the longer term, diabetes may cause other 
health complications including diseases of the large blood vessels (macrovascular disease) such as heart 
attack and stroke, and diseases of the small blood vessels (microvascular disease) such as retinopathy, kidney 
diseases and neuropathy.
How is it managed?
Effective management of type 1 diabetes is crucial to reduce the short- and long-term complications 
associated with the condition. Type 1 diabetes is managed through administering insulin, a careful balance 
of diet and exercise, and regular blood glucose testing to keep blood glucose levels within a safe range. 
Maintaining this balance requires extensive education and ongoing support from health professionals. 
Insulin is delivered through multiple daily injections or continuous infusion via an insulin pump. This insulin 
replacement is essential for survival and, except in cases where a pancreatic transplant occurs, insulin 
is needed every day throughout a person’s life. Continuous glucose monitoring devices are available to 
automatically measure blood glucose levels.
What is an insulin pump?
Insulin pumps are small computerised devices that deliver insulin under the skin. They are worn 24 hours 
a day, and are increasingly being used as an alternative to injecting insulin with a pen or needle. There are 
both clinical and lifestyle benefits to using an insulin pump, but they are expensive (also incurring ongoing 
costs), and often require users to maintain more frequent contact with health professionals than is required 
for insulin injections (AIHW 2012).
About this report
The report presents the prevalence of type 1 diabetes among children aged 0–14, as of 31 December 2013,  
and characteristics such as: sex, age, diagnosis age, duration (time in years since diagnosis) of type 1 diabetes, 
state/territory of residence, residential remoteness area, socioeconomic group, and Indigenous status. 
Additionally, the report looks at the characteristics of insulin pump users aged 0–14, and factors that might 
influence insulin pump use.
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More than 6,000 children had type 1 diabetes 
As of 31 December 2013, 6,091 children aged 0–14  had type 1 diabetes in Australia. This represents 139 cases per 
100,000 population, or 1 in 720 children aged 0–14. 
Prevalence rates similar for boys and girls
Slightly more boys (3,143) than girls (2,947) had type 1 diabetes, reflecting the higher number of boys aged 0–14   
in the overall population. 
The prevalence rates of type 1 diabetes were very similar among boys and girls, with 140 and 139 cases  
per 100,000 population, respectively. 
Almost 2 in 3 were aged 10–14
Almost 2 in 3 children with type 1 diabetes were aged 10–14 (3,891 children), 1,794 were aged 5–9, and 406 were 
aged 0–4. 
The prevalence rates were more than twice as high for children aged 10–14 (278 per 100,000 population) as for 
those aged 5–9 (123 per 100,000), and more than 10 times as high as for those aged 0–4 (27 per 100,000) (Figure 1). 
The rates for girls and boys were relatively similar for all age groups.
Note: Sex was unknown for 1 child.
Source: AIHW analysis of the NDR 2013 as of 31 December 2013 (Table A1).
Figure 1: Prevalence of type 1 diabetes among children aged 0–14, by age and sex, 2013
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Almost 3 in 4 were diagnosed by the age of 9 
About 1 in 5 (21%) children with type 1 diabetes were diagnosed by the age of 3, and almost half (48%) by the 
age of 6. Almost 3 in 4 children (74%) were diagnosed with type 1 diabetes by the age of 9. The remaining 1 in 4 
children were diagnosed at 9–14, with fewer diagnoses as age increased—less than 1% of children with type 1 
diabetes were aged 14 when diagnosed (Table A2).
Average time since diagnosis was 4 years
Longer duration of type 1 diabetes has been associated with an increased risk of long-term complications (see 
Box 1). 
In 2013, the mean length of time (duration) with type 1 diabetes was about 4 years. 
Almost 2 in 3 children (63%, or 3,851) had been diagnosed with type 1 diabetes for 4 years or fewer, and of these,  
1 in 4 had the condition for less than 1 year (984 children). Only a small proportion of children aged 0–14 had 
been diagnosed with type 1 diabetes for 10 years or more (7%, or 421 children) (Figure 2). 
Source: AIHW analysis of the NDR 2013 as of 31 December 2013.
Figure 2: Number of children with type 1 diabetes, by duration of type 1 diabetes, 2013
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Because the long-term complications associated with type 1 diabetes develop gradually over time, children 
diagnosed at a very young age are potentially more vulnerable to poorer health later in life. As such, in this 
cohort of children with type 1 diabetes, those at greatest risk are those aged 0–4, and those aged 5–14 who were 
diagnosed with the condition at a young age. 
Out of 406 children aged 0–4 with type 1 diabetes, 41% had been diagnosed for less than 1 year, and 59% for  
1–4 years. Among children aged 5–9, the majority (57%) had been diagnosed with type 1 diabetes for 1–4 years, 
and almost one-quarter (24%) had been diagnosed for 5–9 years. Among the oldest age group, about 1 in 9 (11%) 
had been diagnosed with type 1 diabetes for 10 or more years, and 36% had been diagnosed for 5–9 years  
(Figure 3).
Source: AIHW analysis of the NDR 2013 as of 31 December 2013 (Table A3).
Figure 3: Duration of type 1 diabetes among children aged 0–14, by age, 2013
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Highest rate was in Tasmania
Prevalence of type 1 diabetes among children was highest for children living in Tasmania (166 cases per 100,000 
population) and lowest in the Northern Territory (50 cases per 100,000). The rates in other states and the Australian 
Capital Territory ranged from 131 to 159 per 100,000 (Figure 4).
The low rate in the Northern Territory may be due to the high proportion of Aboriginal and Torres Strait Islander 
children living there (43%, compared with 6% in Australia; ABS 2013). Indigenous Australians have lower rates of  
type 1 diabetes than other Australians. 
Lowest rates were in remote areas and among  
Indigenous children
Social, economic and environmental conditions can strongly influence health. Typically, health varies among 
different population groups depending on determinants such as geographical remoteness, area of socioeconomic 
disadvantage and Aboriginal and Torres Strait Islander status. However, these results show that the prevalence of  
type 1 diabetes does not appear to be related to these social determinants. 
Source: AIHW analysis of the NDR 2013 as of 31 December 2013 (Table A1).
Figure 4: Prevalence of type 1 diabetes among children aged 0–14, by state/territory of 
residence, 2013 (Number per 100,000 population)
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Remoteness
The majority of children with type 1 diabetes lived in Major cities (66%), followed by Inner regional areas (23%),  
Outer regional areas (9%), and Remote and very remote areas (2%). This pattern reflects the overall population 
distributions for these regions in Australia.
Children living in Remote and very remote areas had the lowest prevalence rate (82 cases per 100,000 population), 
followed by Major cities (133 per 100,000), and Outer regional areas (137 per 100,000). Children living in Inner 
regional areas had the highest rate of type 1 diabetes (169 per 100,000), more than twice as high as for those 
living in Remote and very remote areas (Figure 5).
Socioeconomic disadvantage
The prevalence of type 1 diabetes among children was relatively similar across all socioeconomic groups (based 
on area of usual residence), ranging from 132 per 100,000 population to 150 per 100,000 (Figure 5).
Aboriginal and Torres Strait Islander children
As of 31 December 2013, 167 Aboriginal and Torres Strait Islander children had type 1 diabetes, representing a rate 
of 69 per 100,000 Indigenous children, or 1 in almost 1,500. 
For information about the limitations of data on Aboriginal and Torres Strait Islander people, see Appendix C.
Note: See Appendix C for remoteness and socioeconomic classifications used in this report. 
Source: AIHW analysis of the NDR 2013 as of 31 December 2013 (Table A1).
Figure 5: Prevalence of type 1 diabetes among children aged 0–14, by remoteness area 
and socioeconomic group, 2013 
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Australia’s prevalence rate was 10th highest among  
similar countries
Worldwide, an estimated 497,100 children aged 0–14 have type 1 diabetes (International Diabetes Federation 
2013). Rates varied considerably across Organisation for Economic Co-operation and Development (OECD) member 
countries—from 7 cases per 100,000 population in the Republic of South Korea to 415 per 100,000 in Finland.  
Australia’s prevalence rate of 139 cases per 100,000 population places it as the 10th highest among the 34 OECD 
countries. It was above the OECD average, and in the top third of the member countries. The Australian rate was 
similar to or lower than other, comparable Western countries such as the United States of America (137 per 100,000 
population), Canada (161), and the United Kingdom (173), but was higher than New Zealand (110) (Figure 6).
Notes 
1. The method and data period on which prevalence has been estimated varies for each country. See Table A4 for further details.
2. For OECD countries (excluding Australia) prevalence rates were calculated using 2010 United Nations population projections.
Source: AIHW derived from Patterson et al. (2014) for OECD countries other than Australia; AIHW analysis of NDR 2013 as of 31 December 2013 for Australia.
Figure 6: Estimates of the prevalence of type 1 diabetes for children aged 0–14, by selected 
OECD countries, 2013 (or nearest available year)
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More than 2 in 5 children used an insulin pump
Of the 6,091 children aged 0–14 with type 1 diabetes, 2,612 children, or just over 2 in 5 (43%), were using an 
insulin pump to administer insulin (Table A5). Of these, 51% were girls (1,344) and 49% were boys (1,268).
The majority of insulin pump users were aged 10–14 (66%), 29% were aged 5–9 and 6% were aged less than 5.  
These proportions reflect the age distribution of children with type 1 diabetes. 
Over half (53%) of insulin pump users had been diagnosed with type 1 diabetes for fewer than 5 years (6% for less 
than 1 year), 38% for 5–9 years, 9% for 10 years or longer. 
Insulin pump users had diabetes for longer and were from higher 
socioeconomic groups
In comparing insulin pump users with non-insulin pump users, patterns varied among the subgroups. 
Children with type 1 diabetes using an insulin pump were more likely to:
•	 have had type 1 diabetes for longer—15% of children diagnosed with type 1 diabetes for less than 1 year used  
an insulin pump, compared with 56% of children diagnosed for 10 years or longer
•	 live in the Australian Capital Territory and New South Wales—55% and 52% of children with type 1 diabetes 
living in the Australian Capital Territory and New South Wales were using an insulin pump, respectively, which 
was higher than in Victoria (29%) and Tasmania (41%) 
•	 be from higher socioeconomic groups—55% of children with type 1 diabetes from the highest socioeconomic 
group used an insulin pump, compared with 33% in the lowest socioeconomic group. 
The pattern of insulin pump use among children with type 1 diabetes did not vary greatly by:
•	 sex—46% of girls used an insulin pump, compared with 40% of boys
•	 age—37% of those aged 0–4 had used a pump, compared with 42% of those aged 5–9, and 44% of those  
aged 10–14
•	 remoteness areas—the proportion ranged from 39% to 44% across remoteness areas.
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Appendix A: Summary tables
Table A1: Characteristics of children aged 0–14 with type 1 diabetes, by sex, 2013 
Number Number per 100,000 population
Males Females Persons Males Females Persons
Age group (years)
0–4 228 178 406 29.3 24.1 26.8
5–9 895 899 1,794 119.7 127.1 123.3
10–14 2,020 1,870 3,891 281.9 274.2 278.2
State/territory of residence
New South Wales 966 935 1,901 134.4 137.7 136.0
Victoria 743 752 1,495 137.8 146.9 142.2
Queensland 702 600 1,302 147.9 133.6 140.9
Western Australia 321 310 631 130.4 131.3 130.8
South Australia 255 214 469 168.5 148.5 158.7
Tasmania 85 73 158 172.9 158.8 166.1
Australian Capital Territory 56 47 103 154.8 136.8 146.0
Northern Territory 14 13 27 50.4 49.6 50.0
Remoteness area
Major cities 2,034 1,995 4,029 131.0 135.5 133.2
Inner regional 746 638 1,384 177.0 160.2 168.9
Outer regional 308 258 566 146.1 128.0 137.3
Remote and very remote 50 44 94 84.6 79.4 82.0
Socioeconomic group
Group 5 (least disadvantaged) 592 582 1,174 129.9 134.1 132.0
Group 4 619 590 1,209 139.1 139.8 139.4
Group 3 621 605 1,226 139.3 143.7 141.4
Group 2 661 604 1,265 152.3 146.4 149.5
Group 1 (most disadvantaged) 643 552 1,195 138.7 125.9 132.5
Australia 3,143 2,947 6,091 140.1 138.5 139.4
Note: Totals do not add to the total number of children with type 1 diabetes due to missing information on some variables.
Source: AIHW analysis of the NDR 2013 as of 31 December 2013.
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Table A2: Children with type 1 diabetes, by age at diagnosis, 2013
Age at diagnosis (years) Number Per cent
0 118 1.9
1 534 8.8
2 600 9.9
3 576 9.5
4 593 9.7
0–4 2,421 39.8
5 501 8.2
6 551 9.0
7 492 8.1
8 529 8.7
9 416 6.8
5–9 2,489 40.9
10 436 7.2
11 305 5.0
12 231 3.8
13 154 2.5
14 53 0.9
10–14 1,179 19.4
Total 6,089 100.0
Note: Totals do not add to the total number of children with type 1 diabetes due to missing information  
on some variables.
Source: AIHW analysis of the NDR 2013 as of 31 December 2013.
Table A3: Duration of type 1 diabetes, by age, 2013
Duration of type 1 diabetes (years)
Age group (years) Less than 1 1–4 5–9 10 or more Total
0–4 167 239 . . . . 406
5–9 344 1,027 423 . . 1,794
10–14 473 1,601 1,396 421 3,891
Total 984 2,867 1,819 421 6,091
. .   Not applicable.
Source: AIHW analysis of the NDR 2013 as of 31 December 2013.
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Table A4: Prevalence of type 1 diabetes among children aged 0–14, in OECD countries
Country Data source period Number per 100,000 population
Finland 2000–2005 415.1
Sweden 2005–2007 259.5
Norway 2004–2008 202.6
United Kingdom 2004–2008 173.3
Canada 1990–2010 161.3
Germany 2004–2008 152.6
Denmark 2004–2008 152.3
Estonia 1999–2006 147.2
Iceland 1994–1998 147.0
Australia 2013 139.4
United States of America 2002–2003 136.9
Spain 1995–2011 127.8
Netherlands 1996–1999 125.7
Hungary 2004–2009 123.3
Austria 2004–2008 122.1
Czech Republic 2004–2008 119.7
Poland 2004 112.1
Ireland 1997 110.1
New Zealand 1999–2000 110.0
Luxembourg 2004–2008 108.3
Slovenia 2004–2008 101.6
Belgium 2004–2008 100.8
Portugal 1994–1998 95.7
Switzerland 2004–2008 92.5
Israel 2006–2007 88.6
Slovakia 1999–2003 85.4
France 1998–2004 83.7
Italy 1990–2003 80.6
Greece 2004–2008 79.9
Mexico 2010 38.5
Chile 2000–2005 37.7
Turkey(a) . . 19.8
Japan 1998–2001 15.7
Republic of Korea 1990–1991 6.8
. .    Not applicable. 
(a) Extrapolated using rates from different country.
Notes
1. The majority of data in the International Diabetes Federation 2013 report is sourced from published literature about incidence rates. Prevalence rates were 
  derived from these incidence rates and applied to United Nations 2012 revision population estimates for 2013 for each country to obtain estimates of the 
 number of prevalent cases (Patterson et al. 2014).
2. For OECD countries (excluding Australia) prevalence rates were calculated using 2010 United Nations population projections.
Source: AIHW derived from Patterson et al. (2014) for OECD countries other than Australia; AIHW analysis of NDR 2013 as of 31 December 2013 for Australia. 
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Table A5: Insulin pump use among children aged 0–14 with type 1 diabetes, by selected  
characteristics, 2013
Non-insulin pump users Insulin pump users Total
Sex
Male 1,875 1,268 3,143
Female 1,603 1,344 2,947
Age group (years)
0–4 255 151 406
5–9 1,046 748 1,794
10–14 2,178 1,713 3,891
Duration of type 1 diabetes (years)
Less than 1 832 152 984
1–4 1,623 1,244 2,867
5–9 839 980 1,819
10 or more 185 236 421
State/ territory of residence
New South Wales 907 994 1,901
Victoria 1,059 436 1,495
Queensland 709 593 1,302
Western Australia 371 260 631
South Australia 274 195 469
Tasmania 94 65 159
Australian Capital Territory 46 57 103
Northern Territory 15 12 27
Remoteness area
Major cities 2,280 1,749 4,029
Inner regional 815 568 1,384
Outer regional 320 248 567
Remote and very remote 57 37 94
Socioeconomic group
Group 5 (least disadvantaged) 531 643 1,174
Group 4 670 539 1,209
Group 3 705 521 1,226
Group 2 767 498 1,265
Group 1 (most disadvantaged) 797 399 1,196
Australia 3,479 2,612 6,091
Note: Totals do not add to the total number of children with type 1 diabetes due to missing information on some variables.
Source: AIHW analysis of the NDR 2013 as of 31 December 2013.
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Appendix B: National data sources for type 1 diabetes  
in children
The analysis presented in this report is based on the 2013 National (insulin-treated) Diabetes Register (NDR), 
which captures new cases of insulin-treated diabetes in Australia. The NDR is derived from 2 datasets—National 
Diabetes Services Scheme and Australasian Paediatric Endocrine Group—resulting in robust prevalence estimates 
for children aged 0–14 with type 1 diabetes. 
National Diabetes Services Scheme
The National Diabetes Services Scheme (NDSS) was established in 1987, and is administered by Diabetes Australia. 
It is an initiative of the Australian Government to subsidise the supply of diabetes-related products—such as pens 
and needles to administer insulin, blood glucose test strips and insulin pump consumables—to people who are 
registered with the scheme. A diagnosis of diabetes, substantiated by a health professional, is required to register 
with the NDSS. 
For children, the NDSS provides valid and up-to-date estimates of prevalence of type 1 diabetes. As of  
31 December 2013, this was reported to be 7,292 people aged 15 or under with type 1 diabetes (National 
Diabetes Services Scheme 2013).
Although the requirement for insulin is a strong motivator to register with the NDSS to access subsidised  
diabetes-related products, the diabetes type reported on the NDSS may not always be accurate, and some 
children, especially those with other family members with type 1 diabetes, may not be registered.
Australasian Paediatric Endocrine Group
The Australasian Paediatric Endocrine Group (APEG) is a professional body that represents health professionals 
involved in managing and researching disorders of the endocrine system, including diabetes in children  
and adolescents.
The APEG maintains clinic-based state and territory diabetes registers about children aged under 15 with diabetes. 
The National (insulin-treated) Diabetes Register
The NDR was established in 1999, and collects information about new cases of insulin-treated diabetes in 
Australia. The AIHW maintains the NDR under contract with the Department of Health. For further information 
about the NDR see <http://meteor.aihw.gov.au/content/index.phtml/itemId/608449>.
The NDR is primarily derived from the NDSS and APEG. The NDR 2013 spans 14 years (1999–2013), so for the 
first time captures all children aged 0–14 with type 1 diabetes. The AIHW previously released a report on the 
prevalence of type 1 diabetes in children, but this was based on the NDR 2008, and reported on prevalence 
estimates for children aged 0–9, and projected estimates for those aged 10–14 (AIHW 2011). 
By combining the NDSS and APEG, the NDR provides a reliable and robust data source for reporting on type 
1 diabetes in children in Australia that captures almost all children with type 1 diabetes (AIHW 2015b). The 
Australian Bureau of Statistics (ABS) Australian Health Survey also collects data on diabetes (based on self-report 
and measured data), but it is very limited in its ability to produce comprehensive estimates on children with 
type 1 diabetes (see Box 2). 
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Coverage of type 1 diabetes for children aged 0–14 on the NDR
The capture–recapture method (LaPorte et al. 1993) was used to determine coverage of the NDR. This method 
compares data from several independent, but overlapping, data sources (in this case, the NDSS and APEG) to  
calculate the completeness of a dataset. 
The capture–recapture method was applied to all new cases registered on the NDR in 1999–2013 to establish the 
number of children that may not have been registered on either data source. Over the period, the coverage of 
children with type 1 diabetes on the NDR was estimated to be 99.7%.
Accuracy of diabetes type on the NDR
As part of processing information from the NDSS and APEG to derive the NDR, the reported diabetes type is 
checked. This procedure is unique to the NDR, and helps to ensure that the recorded diabetes type is as accurate 
as possible. This is achieved through:
•	 verifying diabetes type is consistent for those cases on both the NDSS and APEG—where a discrepancy is 
found, the diabetes type is checked by contacting APEG data managers who have access to clinical record 
information
•	 verifying type 1 diabetes status against a set of criteria—because people with type 1 diabetes need insulin to 
survive, the time from diagnosis to first insulin use is a good indicator of a person’s diabetes type. Where this 
time lag is 1 year or less, diabetes type is considered to be type 1. In cases where diabetes is recorded as  
type 1, but the time interval is more than 1 year, or where information on dates is missing, and validation 
cannot be done, the diabetes type is set to ‘missing’. 
Box 2: Other type 1 diabetes prevalence data sources 
The ABS 2011–12 Australian Health Survey provides self-reported and biomedical data that can be used to 
estimate the national prevalence of diabetes. The biomedical component of the survey contained 2 tests 
to detect biomedical signs of diabetes: a measure of fasting plasma glucose, and a measure of glycated 
haemoglobin (HbA1c). However, these biomedical estimates cannot determine diabetes type. 
Information on type 1 diabetes based on parents and/or guardians self-reporting the diabetes status of 
children in their care is not considered accurate enough to provide a true reflection of the number of 
children with type 1 diabetes in Australia.
The ABS estimates that 3,000 children aged less than 15 have type 1 diabetes (ABS 2012), but this estimate 
excludes children under 2, and has a high degree of error (a relative standard error of almost 50%), and 
should be interpreted with caution. 
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Appendix C: Statistical notes and methods
Data quality statement for the NDR
Information about limitations and issues in the NDR are found in the Data Quality Statement: National  
(insulin-treated) Diabetes Register 2013 at: <http://meteor.aihw.gov.au/content/index.phtml/itemId/608449>.
Age of children with type 1 diabetes
These prevalence statistics are presented as of 31 December 2013, so the age of children in the analysis is 
calculated as of that date.
Rates
All rates presented in this report are crude rates per 100,000 population (not age-standardised rates). The crude 
rate is the prevalence of type 1 diabetes relative to the total number of people in the population or  
sub-population of interest.
Estimated resident populations
Throughout this report, population data were used to derive rates of diabetes prevalence. Population data held 
by the AIHW are sourced from the ABS, and are updated as revised or new estimates become available. 
All population estimates currently produced by ABS are based on a usual residence concept; that is, where people 
usually reside. These estimated resident populations are derived from the ABS Census of Population and Housing, 
and adjusted for deaths, births and net migration. The estimated resident populations used in this report are 
based on the preliminary population estimates for 30 June 2013.
Australia’s Aboriginal and Torres Strait Islander population is calculated from the Census, but because of the 
smaller Indigenous population, it is difficult to measure population changes accurately between census years 
using the method described above. Therefore, the ABS developed experimental estimates and projections based 
on the 2011 Census. All calculations of rates for Aboriginal and Torres Strait Islander people use the Series B 
projected Indigenous 2013 populations.
Aboriginal and Torres Strait Islander information on the NDR
The NDR may underestimate the number of Aboriginal and Torres Strait Islander registrants with type 1 diabetes 
for several reasons, as outlined below.
Aboriginal or Torres Strait Islander status
Identifying as an Aboriginal or Torres Strait Islander person on both data sources of the NDR (NDSS and APEG)  
is voluntary.
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NDSS registration form
On the NDSS registration form before 2005, if Indigenous status was not reported, the registrant was recorded as 
non-Indigenous, rather than not stated. This may have overestimated the number of non-Indigenous Australians 
registered, and consequently underestimated the number of Indigenous Australians registered. In 2005 the 
registration form was amended so that in the absence of information about Indigenous status, ‘not stated’ became 
the default value (Health Data Standards Committee 2006). 
Accessing diabetes-related products through programs other than the NDSS
Other programs that provide Indigenous Australians access to diabetes-related products might result in low 
registration rates for the NDSS, and subsequently the NDR, among Aboriginal and Torres Strait Islander people.
For example, programs operating under Section 100 of the National Health Act 1953—such as Aboriginal Medical 
Services and the National Aboriginal Community Controlled Health Organisation—give Indigenous Australians 
access to products that people with insulin-treated diabetes need. 
In addition, NDSS Access Points are not always available in remote areas, limiting the access of many Indigenous 
Australians to NDSS services.
Missing data
Indigenous status was unknown for 11% of the cohort for this report. 
Australian Statistical Geography Standard
Geographic location was classified according to the ABS’s Australian Statistical Geography Standard 2011 
Remoteness Areas, which groups geographic areas into categories. 
These categories are defined using the Accessibility/Remoteness Index for Australia—a measure of the 
remoteness of a location from the services provided by large towns or cities. Accessibility is judged purely on 
distance to 1 of the metropolitan centres, so it provides a relative indication of how difficult it might be for 
residents to access some services, such as health care and education.
The categories used in this publication are:
•	 Major cities
•	 Inner regional
•	 Outer regional
•	 Remote and very remote.
Some postcodes might not map to areas used in the 2011 Census, and were not included in relevant tables. 
Further, some postcodes might have changed remoteness area since the 2011 Census, but are still included under 
the area they were assigned in 2011.
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Index of Relative Socio-Economic Disadvantage
Socioeconomic classifications were based on the ABS Index of Relative Socio-Economic Disadvantage. 
Geographic areas are assigned a score based on attributes such as income, educational attainment, levels of 
public sector housing, unemployment and jobs in skilled or unskilled occupations. 
A low score means an area has more low-income families, people with little training, and high unemployment, 
and may be considered disadvantaged relative to other areas with higher scores. Areas with high index scores 
may be considered less disadvantaged relative to other areas. 
High scores reflect a relative lack of disadvantage, rather than advantage, and the Index of Relative Socio-Economic 
Disadvantage relates to the average disadvantage of all people living in a geographic area. It cannot be presumed 
to apply to all individuals living in the area. 
In this report, a person’s socioeconomic status was classified using their residential postcode according to the 
Index of Relative Socio-Economic Disadvantage for 2011. Five population-based socioeconomic groups (fifths), 
based on the level of the index, were used for analyses, where group 1 represents the lowest socioeconomic 
status of the population, and group 5 the highest socioeconomic status.
Geographic areas may be excluded where no score is determined due to low populations or high levels of  
non-response in the underlying census. Additionally, some postcodes may not map to the areas used in the 2011 
Census, and were also excluded. Further, some postcodes might have changed socioeconomic group since the 
2011 Census, but are still included under the area they were assigned in 2011.
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Prevalence of type 1 diabetes among children aged 0–14 in Australia 2013 presents the  
first national picture of children aged 0–14 living with type 1 diabetes in Australia.  
The report, based on data from the National (insulin-treated) Diabetes Register, 
highlights that in 2013, 6,091 children aged 0–14 had type 1 diabetes in Australia— 
this represented 139 cases per 100,000 population. About 2 in 5 children with  
type 1 diabetes used an insulin pump to administer insulin. The prevalence of  
type 1 diabetes among children differed by age, state/territory, and residential 
remoteness areas.
